Henry Schein appoints Frederick M. Lowery as CEO, Succeeding Longtime Leader Stanley Bergman

Melville, NY, January 12, 2026 (Business Wire) -- Henry Schein, Inc. announced the appointment of Frederick M. Lowery as Chief Executive Officer, effective March 2, 2026, at which point he will also join the Board of Directors. Lowery succeeds Stanley M. Bergman, who will step down after 35 years as CEO and continue as Chairman to support a smooth leadership transition.

Lowery brings more than 20 years of healthcare distribution and operational leadership experience, most recently serving as Executive Vice President and President of Laboratory Products and BioProduction at Thermo Fisher Scientific, where he led above-market growth of the Fisher Scientific distribution business. His background spanning distribution, manufacturing, R&D, marketing, and sales closely aligns with Henry Schein’s integrated business model and its ongoing BOLD+1 strategy, positioning him to guide the company through its next phase of growth and value creation.

Read full article here.